Pierre Kyme - 19 Jun 2024 Form 3/A - Amendment Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Issuer symbol
ARMP
Transactions as of
19 Jun 2024
Net transactions value
$0
Form type
3/A - Amendment
Filing time
25 Apr 2025, 16:05:16 UTC
Date Of Original Report
28 Jun 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARMP Common Stock 1,518 19 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARMP Stock Options (Right to Buy) 19 Jun 2024 Common Stock 22,000 $3.15 Direct F2
holding ARMP Stock Options (Right to Buy) 19 Jun 2024 Common Stock 25,000 $3.05 Direct F3
holding ARMP Stock Options (Right to Buy) 19 Jun 2024 Common Stock 15,000 $5.14 Direct F4
holding ARMP Stock Options (Right to Buy) 19 Jun 2024 Common Stock 50,000 $5.11 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the reporting person's original Form 3.
F2 These Stock Options were omitted from the reporting person's original Form 3. Twenty-five percent (25%) of the Stock Options vested on each annual anniversary of the grant date. The Stock Options were granted on May 22, 2019.
F3 These Stock Options were omitted from the reporting person's original Form 3. Twenty-five percent (25%) of the Stock Options vested on each annual anniversary of the grant date. The Stock Options were granted on April 1, 2020.
F4 These Stock Options were omitted from the reporting person's original Form 3. Twenty-five percent (25%) of the Stock Options vested on each annual anniversary of the grant date. The Stock Options were granted on March 25, 2021.
F5 These Stock Options were omitted from the reporting person's original Form 3. Twenty-five percent (25%) of the Stock Options vested on each of the first, second and third annual anniversary of the grant date. The remaining twenty-five percent (25%) of the Stock Options will vest on the fourth annual anniversary of the grant date. The Stock Options were granted on April 13, 2022.